Derivation of induced pluripotent stem cells by retroviral gene transduction in mammalian species

Masanori Imamura, Hironobu Okuno, Ikuo Tomioka, Yoshimi Kawamura, Zachary Yu Ching Lin, Ryusuke Nakajima, Wado Akamatsu, Hirotaka James Okano, Yumi Matsuzaki, Erika Sasaki, Hideyuki Okano

Research output: Chapter in Book/Report/Conference proceedingChapter

7 Citations (Scopus)

Abstract

Pluripotent stem cells can provide us with an enormous cell source for in vitro model systems for development. In 2006, new methodology was designed to generate pluripotent stem cells directly from somatic cells, and these cells were named induced pluripotent stem cells (iPSCs). This method consists of technically simple procedures: donor cell preparation, gene transduction, and isolation of embryonic stem cell-like colonies. The iPSC technology enables cell biologists not only to obtain pluripotent stem cells easily but also to study the reprogramming events themselves. Here, we describe the protocols to generate iPSCs from somatic origins by using conventional viral vectors. Specifically, we state the usage of three mammalian species: mouse, common marmoset, and human. As mouse iPSC donors, fibroblasts are easily prepared, while mesenchymal stem cells are expected to give rise to highly reprogrammed iPSCs efficiently. Common marmoset (Callithrix jacchus), a nonhuman primate, represents an alternative model to the usual laboratory animals. Finally, patient-specific human iPSCs give us an opportunity to examine the pathology and mechanisms of dysregulated genomic imprinting. The iPSC technology will serve as a valuable method for studying genomic imprinting, and conversely, the insights from these studies will offer valuable criteria to assess the potential of iPSCs.

Original languageEnglish
Title of host publicationMethods in Molecular Biology
Pages21-48
Number of pages28
Volume925
DOIs
Publication statusPublished - 2012

Publication series

NameMethods in Molecular Biology
Volume925
ISSN (Print)10643745

Fingerprint

Induced Pluripotent Stem Cells
Callithrix
Pluripotent Stem Cells
Genes
Genomic Imprinting
Tissue Donors
Technology
Laboratory Animals
Embryonic Stem Cells
Mesenchymal Stromal Cells
Primates
Fibroblasts
Pathology

Keywords

  • Cell culture
  • Common marmoset
  • Disease model
  • Embryonic stem cells
  • Epigenetics
  • Genomic imprinting
  • Germ cells
  • Induced pluripotent stem cells
  • Pluripotency
  • Repro-gramming

ASJC Scopus subject areas

  • Molecular Biology
  • Genetics

Cite this

Imamura, M., Okuno, H., Tomioka, I., Kawamura, Y., Lin, Z. Y. C., Nakajima, R., ... Okano, H. (2012). Derivation of induced pluripotent stem cells by retroviral gene transduction in mammalian species. In Methods in Molecular Biology (Vol. 925, pp. 21-48). (Methods in Molecular Biology; Vol. 925). https://doi.org/10.1007/978-1-62703-011-3-2

Derivation of induced pluripotent stem cells by retroviral gene transduction in mammalian species. / Imamura, Masanori; Okuno, Hironobu; Tomioka, Ikuo; Kawamura, Yoshimi; Lin, Zachary Yu Ching; Nakajima, Ryusuke; Akamatsu, Wado; Okano, Hirotaka James; Matsuzaki, Yumi; Sasaki, Erika; Okano, Hideyuki.

Methods in Molecular Biology. Vol. 925 2012. p. 21-48 (Methods in Molecular Biology; Vol. 925).

Research output: Chapter in Book/Report/Conference proceedingChapter

Imamura, M, Okuno, H, Tomioka, I, Kawamura, Y, Lin, ZYC, Nakajima, R, Akamatsu, W, Okano, HJ, Matsuzaki, Y, Sasaki, E & Okano, H 2012, Derivation of induced pluripotent stem cells by retroviral gene transduction in mammalian species. in Methods in Molecular Biology. vol. 925, Methods in Molecular Biology, vol. 925, pp. 21-48. https://doi.org/10.1007/978-1-62703-011-3-2
Imamura M, Okuno H, Tomioka I, Kawamura Y, Lin ZYC, Nakajima R et al. Derivation of induced pluripotent stem cells by retroviral gene transduction in mammalian species. In Methods in Molecular Biology. Vol. 925. 2012. p. 21-48. (Methods in Molecular Biology). https://doi.org/10.1007/978-1-62703-011-3-2
Imamura, Masanori ; Okuno, Hironobu ; Tomioka, Ikuo ; Kawamura, Yoshimi ; Lin, Zachary Yu Ching ; Nakajima, Ryusuke ; Akamatsu, Wado ; Okano, Hirotaka James ; Matsuzaki, Yumi ; Sasaki, Erika ; Okano, Hideyuki. / Derivation of induced pluripotent stem cells by retroviral gene transduction in mammalian species. Methods in Molecular Biology. Vol. 925 2012. pp. 21-48 (Methods in Molecular Biology).
@inbook{640d6d08548b40d392b451915b78f2e0,
title = "Derivation of induced pluripotent stem cells by retroviral gene transduction in mammalian species",
abstract = "Pluripotent stem cells can provide us with an enormous cell source for in vitro model systems for development. In 2006, new methodology was designed to generate pluripotent stem cells directly from somatic cells, and these cells were named induced pluripotent stem cells (iPSCs). This method consists of technically simple procedures: donor cell preparation, gene transduction, and isolation of embryonic stem cell-like colonies. The iPSC technology enables cell biologists not only to obtain pluripotent stem cells easily but also to study the reprogramming events themselves. Here, we describe the protocols to generate iPSCs from somatic origins by using conventional viral vectors. Specifically, we state the usage of three mammalian species: mouse, common marmoset, and human. As mouse iPSC donors, fibroblasts are easily prepared, while mesenchymal stem cells are expected to give rise to highly reprogrammed iPSCs efficiently. Common marmoset (Callithrix jacchus), a nonhuman primate, represents an alternative model to the usual laboratory animals. Finally, patient-specific human iPSCs give us an opportunity to examine the pathology and mechanisms of dysregulated genomic imprinting. The iPSC technology will serve as a valuable method for studying genomic imprinting, and conversely, the insights from these studies will offer valuable criteria to assess the potential of iPSCs.",
keywords = "Cell culture, Common marmoset, Disease model, Embryonic stem cells, Epigenetics, Genomic imprinting, Germ cells, Induced pluripotent stem cells, Pluripotency, Repro-gramming",
author = "Masanori Imamura and Hironobu Okuno and Ikuo Tomioka and Yoshimi Kawamura and Lin, {Zachary Yu Ching} and Ryusuke Nakajima and Wado Akamatsu and Okano, {Hirotaka James} and Yumi Matsuzaki and Erika Sasaki and Hideyuki Okano",
year = "2012",
doi = "10.1007/978-1-62703-011-3-2",
language = "English",
isbn = "9781627030106",
volume = "925",
series = "Methods in Molecular Biology",
pages = "21--48",
booktitle = "Methods in Molecular Biology",

}

TY - CHAP

T1 - Derivation of induced pluripotent stem cells by retroviral gene transduction in mammalian species

AU - Imamura, Masanori

AU - Okuno, Hironobu

AU - Tomioka, Ikuo

AU - Kawamura, Yoshimi

AU - Lin, Zachary Yu Ching

AU - Nakajima, Ryusuke

AU - Akamatsu, Wado

AU - Okano, Hirotaka James

AU - Matsuzaki, Yumi

AU - Sasaki, Erika

AU - Okano, Hideyuki

PY - 2012

Y1 - 2012

N2 - Pluripotent stem cells can provide us with an enormous cell source for in vitro model systems for development. In 2006, new methodology was designed to generate pluripotent stem cells directly from somatic cells, and these cells were named induced pluripotent stem cells (iPSCs). This method consists of technically simple procedures: donor cell preparation, gene transduction, and isolation of embryonic stem cell-like colonies. The iPSC technology enables cell biologists not only to obtain pluripotent stem cells easily but also to study the reprogramming events themselves. Here, we describe the protocols to generate iPSCs from somatic origins by using conventional viral vectors. Specifically, we state the usage of three mammalian species: mouse, common marmoset, and human. As mouse iPSC donors, fibroblasts are easily prepared, while mesenchymal stem cells are expected to give rise to highly reprogrammed iPSCs efficiently. Common marmoset (Callithrix jacchus), a nonhuman primate, represents an alternative model to the usual laboratory animals. Finally, patient-specific human iPSCs give us an opportunity to examine the pathology and mechanisms of dysregulated genomic imprinting. The iPSC technology will serve as a valuable method for studying genomic imprinting, and conversely, the insights from these studies will offer valuable criteria to assess the potential of iPSCs.

AB - Pluripotent stem cells can provide us with an enormous cell source for in vitro model systems for development. In 2006, new methodology was designed to generate pluripotent stem cells directly from somatic cells, and these cells were named induced pluripotent stem cells (iPSCs). This method consists of technically simple procedures: donor cell preparation, gene transduction, and isolation of embryonic stem cell-like colonies. The iPSC technology enables cell biologists not only to obtain pluripotent stem cells easily but also to study the reprogramming events themselves. Here, we describe the protocols to generate iPSCs from somatic origins by using conventional viral vectors. Specifically, we state the usage of three mammalian species: mouse, common marmoset, and human. As mouse iPSC donors, fibroblasts are easily prepared, while mesenchymal stem cells are expected to give rise to highly reprogrammed iPSCs efficiently. Common marmoset (Callithrix jacchus), a nonhuman primate, represents an alternative model to the usual laboratory animals. Finally, patient-specific human iPSCs give us an opportunity to examine the pathology and mechanisms of dysregulated genomic imprinting. The iPSC technology will serve as a valuable method for studying genomic imprinting, and conversely, the insights from these studies will offer valuable criteria to assess the potential of iPSCs.

KW - Cell culture

KW - Common marmoset

KW - Disease model

KW - Embryonic stem cells

KW - Epigenetics

KW - Genomic imprinting

KW - Germ cells

KW - Induced pluripotent stem cells

KW - Pluripotency

KW - Repro-gramming

UR - http://www.scopus.com/inward/record.url?scp=84867552570&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84867552570&partnerID=8YFLogxK

U2 - 10.1007/978-1-62703-011-3-2

DO - 10.1007/978-1-62703-011-3-2

M3 - Chapter

SN - 9781627030106

VL - 925

T3 - Methods in Molecular Biology

SP - 21

EP - 48

BT - Methods in Molecular Biology

ER -